All In Biotech

Drug Trial Radar · NCT06041269

A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)

A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis

Last checked: Nov 19, 2026Latest source record: Nov 25, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 420 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

420

Planned (sponsor's estimate)

Start

Aug 31, 2023

Primary completion

Nov 29, 2024

Study completion May 30, 2025

Sponsor

Lead sponsor
AnaptysBio, Inc.Industry
Sponsor type
Industry
First posted
Sep 18, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RENOIR Study: This study will evaluate the safety, tolerability, and efficacy of Rosnilimab in subjects with moderate to severe Rheumatoid Arthritis (RA)

Conditions

  • Rheumatoid Arthritis

Interventions

  • RosnilimabDrug

    PD-1 agonist antibody

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change from Baseline in 28-Joint Disease Activity Score based on CRP (DAS28-CRP) at Week 12Time frame: Baseline to Week 12

Locations

92 sites in 15 countries. Site status is shown where the registry gives one.

  • AnaptysBio Investigative Site 10-132

    Flagstaff, Arizona

  • AnaptysBio Investigative Site 10-130

    Glendale, Arizona

  • AnaptysBio Investigative Site 10-129

    Phoenix, Arizona

  • AnaptysBio Investigative Site 10-131

    Tucson, Arizona

  • AnaptysBio Investigative Site 10-105

    Covina, California

  • Anaptys Bio Investigative Site 10-119

    Rancho Mirage, California

  • AnaptysBio Investigative Site 10-113

    San Diego, California

  • AnaptysBio Investigative Site 10-127

    San Francisco, California

  • AnaptysBio Investigative Site 10-136

    Temecula, California

  • AnaptysBio Investigative Site 10-133

    Upland, California

  • AnaptysBio Investigative Site 10-112

    Whitter, California

  • AnaptysBio Investigative Site 10-103

    Aventura, Florida

  • AnaptysBio Investigative Site 10-141

    Avon Park, Florida

  • AnaptysBio Investigative Site 10-118

    Boynton Beach, Florida

  • AnaptysBio Investigative Site 10-125

    Daytona Beach, Florida

  • AnaptysBio Investigative Site 10-122

    Homestead, Florida

  • Anaptys Bio Investigative Site 10-142

    Miami, Florida

  • AnaptysBio Investigative Site 10-140

    Miami, Florida

  • AnaptysBio Investigative Site 10-102

    Miami, Florida

  • AnaptysBio Investigative Site 10-124

    Plantation, Florida

  • AnaptysBio Investigative Site 10-139

    West Palm Beach, Florida

  • AnaptysBio Investigative Site 10-114

    Chicago, Illinois

  • AnaptysBio Investigative Site 10-145

    Monroe, Louisiana

  • AnaptysBio Investigative Site 10-143

    Brookline, Massachusetts

  • AnaptysBio Investigative Site 10-116

    Albuquerque, New Mexico

  • AnaptysBio Investigative Site 10-148

    Smithfield, North Carolina

  • AnaptysBio Investigative Site 10-146

    Middleburg Heights, Ohio

  • AnaptysBio Investigative Site 10-101

    Jackson, Tennessee

  • AnaptysBio Investigative Site 10-120

    Allen, Texas

  • AnaptysBio Investigative Site 10-107

    Colleyville, Texas

  • AnaptysBio Investigative Site 10-123

    Katy, Texas

  • AnaptysBio Investigative Site 10-108

    Mesquite, Texas

  • AnaptysBio Investigative Site 10-110

    Plano, Texas

  • AnaptysBio Investigative Site 10-106

    The Woodlands, Texas

  • AnaptysBio Investigative Site 10-121

    Tomball, Texas

  • AnaptysBio Investigative Site 10-117

    Beckley, West Virginia

  • AnaptysBio Investigative Site 13-103

    Antwerp, Belgium

  • AnaptysBio Investigative Site 13-102

    Anderlecht, Brussels Capital, Belgium

  • AnaptysBio Investigative Site 13- 105

    Liège, Liège, Belgium

  • AnaptysBio Investigative Site 13-104

    Leuven, Vlaams-Braba, Belgium

Showing 40 of 92 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.